Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.

J Clin Virol

Normandy University, France; University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB), Research group on antimicrobial agents and microorganisms (GRAM, EA 2656), F-76000 Rouen, France; Rouen University Hospital, Associate Laboratory of the National Reference Center for HIV, F-76000 Rouen, France. Electronic address:

Published: August 2014

We report the case of a multi-experienced patient, infected with an HIV-1 strain, with selected multiple resistance mutations. We designed a novel well-tolerated and effective rescue treatment including dolutegravir, rilpivirine, and foscarnet, allowing a 60-week sustained virological response for the first time in 23 years of HIV infection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2014.05.004DOI Listing

Publication Analysis

Top Keywords

dolutegravir rilpivirine
8
association dolutegravir
4
rilpivirine enhanced
4
enhanced foscarnet
4
foscarnet induction
4
induction effective
4
effective salvage
4
salvage antiretroviral
4
antiretroviral therapy
4
therapy report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!